Green Pharmaceuticals suggests SnoreStop to renew marriages
CAMARILLO, Calif. Green Pharmaceuticals on Valentine’s Day unveiled its “Renew Your Marriage” promotion to help promote its core SnoreStop brand, a natural remedy that helps relieve snoring.
The company is currently reviewing submissions from consumers at snorestop.com that cite “the impact snoring has made on their relationship and how other stop-snoring strategies and products have failed to turn down the volume in their bedroom.”
Green plans to select five couples from around the country to receive a year’s supply of SnoreStop products and will either fund a Snore-Stop-branded wedding or a second honeymoon for the couples.
SnoreStop’s Renew Your Marriage Promotion marks the first in a series of planned initiatives under the company’s new “Save Your Marriage” umbrella campaign. Almost three years ago, the company garnered international media attention with its forehead advertising campaign in conjunction with entrepreneur Andrew Fischer.
“As we host more and more marriage renewal wedding ceremonies across the country,” stated Christian De Rivel, vice president of sales and marketing for Green, “we hope we will encourage couples everywhere to give SnoreStop a try even if other products have let them down.”
Isma Benattia named Wyeth Consumer Healthcare head of global R&D
MADISON, N.J. Wyeth Consumer Healthcare announced that Isma Benattia has been named executive vice president of Global Research and Development, effective immediately.
In her new role, Benattia will be in charge of bringing new products to market and managing regulatory necessities regarding Wyeth’s over-the-counter products.
Benattia has served at Wyeth Pharmaceuticals since 2003, where she most recently was vice president in charge of Global Labeling. She previously held the position of executive medical director of neuroscience, where she played a leading role in managing scientific and regulatory issues involving Effexor, Wyeth’s second largest brand in terms of global revenue.
Prior to joining Wyeth, Benattia led global clinical programs for major products at Pfizer and Eli Lilly. She holds Master’s degrees in Pharmacology and Psychotropic Drugs; Methodology of Clinical Research and Medical and Marketing Management.
Study shows Relacore may reduce acne flare-ups
NEW YORK Carter Reed on Friday released studies that suggests its dietary supplement diet aid Relacore may be useful in reducing acne flare-ups.
“One of the reasons Relacore has been so successful is because people buy it along with other diet pills or to use in conjunction with any sensible diet and exercise plan,” stated Gina Daines, Carter-Reed’s director of marketing. “Now when it comes to acne, we’re seeing the same phenomenon—those who buy popular anti-acne treatments, like Proactive, are picking up a bottle of Relacore to expand and complete their anti-acne regimen, using Relacore to help prevent the stress-related increase, duration, frequency and severity of acne flare-ups.”